passage of the food and drug administrations safety and innovation act of 2012, or what we fondly called fdasi. to improve patient access to new and better treatments, and to alleviate drug some shortages. fdasia also gives the fda important new authorities to protect the integrity of the to -- drug supply chain. thanks to fdasia we will receive enhanced information about drug manufacturers and the establishment and have the authority to develop a risk-based scheduled to inspect those establishment. we will be able to obtain records prior to an inspection, and fda can refuse drugs to the u.s. which were manufacturing for the substance that delayed, denied, limited or refused fda inspection. fda also now has the authority to put in place new processes to allow for the destruction of small mail packages of illegal drugs, which will deter purchases from illegal foreign internet pharmacies. under fdasia, communications with foreign regulatory agencies will improve. the definition of good manufacturing practices is more explicit, including quality systems and risk management. and registration of co